Invivyd (IVVD) Non-Current Assets (2021 - 2025)

Invivyd (IVVD) reported Non-Current Assets of $29.4 million for Q4 2025, up 2.02% on a YoY basis from $28.8 million in Q4 2024, and little changed quarter-over-quarter from $29.4 million in Q3 2025.

Invivyd (IVVD) Non-Current Assets (2021 - 2025) Analysis & Trends

Invivyd has reported Non-Current Assets for 5 years, with the latest figure at $29.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets rose 2.02% year-over-year to $29.4 million; the trailing twelve-month figure through Dec 2025 stood at $116.6 million (up 135.16% YoY), and the FY2025 full-year result was $29.4 million, up 2.02% from the prior year.
  • Non-Current Assets for Q4 2025 stood at $29.4 million, roughly flat from $29.4 million in the prior quarter.
  • The five-year high for Non-Current Assets was $29.9 million in Q2 2025, with the low at $1.9 million in Q2 2021.
  • Historically, Non-Current Assets has averaged $11.2 million across 5 years, with a median of $5.6 million in 2024.
  • Annual changes were most pronounced in 2022 — Non-Current Assets plunged 48.47% — and 2025, when it jumped 588.74%.
  • Invivyd's Non-Current Assets stood at $3.4 million in 2021, then surged by 84.91% to $6.2 million in 2022, then sank by 31.2% to $4.3 million in 2023, then jumped by 570.56% to $28.8 million in 2024, then advanced by 2.02% to $29.4 million in 2025.
  • The last three Non-Current Assets figures came in at $29.4 million (Q4 2025), $29.4 million (Q3 2025), and $29.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Invivyd 168.41 Mn -58.28 Mn - 29.42 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 29.42 Mn
Sep 30, 2025 29.39 Mn
Jun 30, 2025 29.86 Mn
Mar 31, 2025 27.92 Mn
Dec 31, 2024 28.83 Mn
Sep 30, 2024 10.82 Mn
Jun 30, 2024 4.34 Mn
Mar 31, 2024 5.59 Mn
Dec 31, 2023 4.30 Mn
Sep 30, 2023 4.81 Mn
Jun 30, 2023 5.43 Mn
Mar 31, 2023 5.94 Mn
Dec 31, 2022 6.25 Mn
Sep 30, 2022 3.15 Mn
Jun 30, 2022 3.25 Mn
Mar 31, 2022 1.97 Mn
Dec 31, 2021 3.38 Mn
Sep 30, 2021 6.12 Mn
Jun 30, 2021 1.93 Mn